Ranbaxy Receives Tentative Approval For Valsartan Tablets
To Benefit from 180 day exclusivity, at launch, due to its First To File status PRINCETON, N.J., Oct. 29 /PRNewswire/ -- Ranbaxy Pharmaceuticals Inc. (RPI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced today that RLL has received te...Blood Pressure Drug May Not Ease Irregular Heartbeat
... Despite earlier promise, valsartan fails to deliver against atrial fibrillation, rese...ril 15 (HealthDay News) -- The blood pressure drug valsartan may not prevent episodes of a dangerous abnormal h...tudy finds. Earlier research had suggested that valsartan (Diovan) might reduce the occurrence of atrial fib...Is telmisartan effective in treating non-alcoholic steatohepatitis?
.... They compared the efficacy of telmisartan vs valsartan in a randomized double blind pilot trial assessing...was to prove certain superiority of telmisartan vs valsartan probably linked to its specific insulin sensitizin...d trials evaluating the effects of telmisartan and valsartan in steatohepatitis that uses paired liver biopsies...JCI table of contents: Oct. 25, 2007
... suggested that treatment with certain antihypertensive agents might be of benefit to individuals with, or at high risk of developing, AD. TITLE: valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease AUTHOR CONTACT: Giulio Maria Pasinett...Blood Pressure Drug Might Work Against Alzheimer's
...ct. 25 (HealthDay News) -- The blood pressure drug valsartan shows the ability to reduce Alzheimer's disease-li...ith seven candidates," Pasinetti said, adding that valsartan was the most promising of the lot. Specifically, valsartan interfered with the formation of clumps of the pro...U of M study: Early treatment can reverse heart damage
...bo. At the 12-month mark after both groups were taking the drug every patient showed better Rasmussen Disease Scores, effectively demonstrating that valsartan can slow progression and even reverse early cardiovascular disease in asymptomatic high-risk patients. The findings of the study are published in the ...Combination Drug Therapy For Hypertension
...ican Society of Hypertension in New York, Ridker informed the importance of valsartan (Diovan), an angiotensin receptor blocker in people with hypertension. Further a combination of valsartan with a standard diuretic can bring the blood pressure further below. ...Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events in Landmark Jikei Heart Study
..."hugin" href="http://www.novartis.com/">http://www.novartis.com . References [1] Mochizuki S et al. valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-...